Standard BioTools Inc.
LAB
$1.06
-$0.015-1.40%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 154.91% | 184.31% | 177.37% | 199.14% | -30.70% |
| Total Receivables | 70.95% | 113.27% | 114.57% | 148.29% | 13.77% |
| Inventory | 98.40% | 94.48% | 93.02% | 79.27% | -4.38% |
| Prepaid Expenses | 176.97% | 173.68% | 187.55% | 164.14% | -26.91% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 137.58% | 165.67% | 162.21% | 180.91% | -24.23% |
|
|
|||||
| Total Current Assets | 137.58% | 165.67% | 162.21% | 180.91% | -24.23% |
| Net Property, Plant & Equipment | 30.14% | 29.64% | 30.65% | 7.38% | -7.87% |
| Long-term Investments | 4.68% | 0.11% | -0.03% | -0.02% | 0.06% |
| Goodwill | 4.68% | 0.11% | -0.03% | -0.02% | 0.06% |
| Total Other Intangibles | 1,968.14% | 446.72% | 232.48% | 294.65% | -89.38% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 986.61% | 1,021.63% | 866.24% | 843.99% | -9.72% |
| Total Assets | 89.54% | 100.88% | 99.18% | 109.24% | -17.23% |
|
|
|||||
| Total Accounts Payable | 32.98% | 49.12% | 106.44% | 115.11% | 16.70% |
| Total Accrued Expenses | 34.34% | 35.97% | 23.82% | 14.87% | 113.92% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -90.25% | 579.68% | 613.76% | 752.33% | 1,007.60% |
| Total Finance Division Other Current Liabilities | 27.90% | 37.98% | 93.46% | 98.44% | -9.40% |
| Total Other Current Liabilities | 27.90% | 37.98% | 93.46% | 98.44% | -9.40% |
| Total Current Liabilities | -39.73% | 132.85% | 164.32% | 177.60% | 151.66% |
|
|
|||||
| Total Current Liabilities | -39.73% | 132.85% | 164.32% | 177.60% | 151.66% |
| Long-Term Debt | -92.49% | -99.50% | -99.51% | -99.52% | -93.66% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -12.86% | -9.66% | -8.11% | -6.16% | -10.88% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 196.40% | 150.71% | 145.48% | 150.98% | -19.86% |
| Total Liabilities | -12.04% | 20.32% | 25.65% | 27.16% | -0.41% |
|
|
|||||
| Common Stock & APIC | 97.77% | 97.06% | 97.16% | 97.03% | 1.63% |
| Retained Earnings | -18.48% | -17.39% | -17.15% | -14.42% | -8.06% |
| Treasury Stock & Other | -451.87% | -517.60% | -589.68% | -331.95% | -233.39% |
| Total Common Equity | 418.62% | 471.49% | 550.02% | 694.23% | -81.73% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | 0.00% |
|
|
|||||
| Total Common Equity | 418.62% | 471.49% | 550.02% | 694.23% | -81.73% |
| Total Preferred Equity | -- | -- | -- | -- | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 189.04% | 172.56% | 157.88% | 169.65% | -28.98% |
|
|
|||||
